N01.4 Rapidly progressive nephritic syndrome with diffuse endocapillary proliferative glomerulonephritis

Name of the Condition

• Rapidly Progressive Nephritic Syndrome with Diffuse Endocapillary Proliferative Glomerulonephritis
• ICD-10 Code: N01.4

Summary

Rapidly progressive nephritic syndrome with diffuse endocapillary proliferative glomerulonephritis is a severe kidney disorder marked by rapid loss of kidney function due to inflammation and proliferation of cells within the glomeruli, the kidney's filtering units. This condition presents with hematuria (blood in urine), proteinuria (excess protein in urine), and a swift decline in renal function, potentially leading to acute kidney injury within weeks. The diffuse endocapillary proliferative pattern indicates widespread structural changes in the glomeruli, requiring urgent medical intervention to mitigate irreversible damage.

Causes

This condition is typically caused by immune-mediated damage to the glomeruli, which may result from autoimmune diseases (such as vasculitis or lupus), infections, or exposure to certain medications. The diffuse endocapillary proliferative pattern suggests a specific type of glomerular injury, often linked to immune complex deposition or antibody-mediated processes. In some cases, the underlying cause remains idiopathic (unknown), but the condition is distinguished by its aggressive progression.

Risk Factors

• Autoimmune conditions: Diseases like lupus or vasculitis that affect the kidneys.
• Infections: Recent bacterial or viral infections that trigger immune responses.
• Medications: Use of drugs known to induce glomerular injury (e.g., certain antibiotics or NSAIDs).
• Genetic predisposition: Family history of kidney disease or autoimmune disorders.

Symptoms

• Hematuria (visible or microscopic blood in urine).
• Proteinuria (excess protein in urine, often causing foamy urine).
• Rapid decline in kidney function (e.g., rising creatinine levels).
• Hypertension (high blood pressure).
• Edema (swelling, particularly in the legs or face).
• Fatigue or malaise.
• Reduced urine output.

Diagnosis

Diagnosis involves a combination of clinical evaluation, laboratory tests, and renal biopsy. Urinalysis typically shows hematuria and proteinuria, while blood tests may reveal elevated creatinine or urea levels indicating impaired kidney function. A renal biopsy is critical to confirm the diffuse endocapillary proliferative pattern and rule out other glomerular diseases. Additional tests, such as serology for autoimmune markers or infectious agents, may help identify underlying causes.

Treatment Options

Treatment focuses on addressing the underlying cause and slowing disease progression. Immunosuppressive therapies (e.g., corticosteroids, cyclophosphamide) are often used to reduce inflammation. Plasmapheresis may be employed in severe cases to remove harmful antibodies. Supportive care includes managing blood pressure, reducing proteinuria, and addressing complications like edema or electrolyte imbalances. Kidney replacement therapy (dialysis) may be necessary if renal function declines significantly.

Prognosis and Follow-Up

Prognosis depends on the underlying cause, timeliness of treatment, and response to therapy. Early intervention improves outcomes, but some patients may progress to chronic kidney disease or require long-term dialysis. Regular follow-up with nephrology is essential to monitor kidney function, adjust treatments, and manage complications. Lifelong surveillance for recurrence or associated conditions (e.g., autoimmune diseases) is often necessary.

Complications

• Acute kidney injury or end-stage renal disease requiring dialysis.
• Hypertension or uncontrolled blood pressure.
• Electrolyte imbalances (e.g., hyperkalemia).
• Increased risk of infections due to immunosuppressive therapy.
• Cardiovascular complications from chronic kidney disease.

Lifestyle & Prevention

• Manage underlying conditions (e.g., autoimmune diseases) with prescribed medications.
• Avoid nephrotoxic drugs (e.g., certain NSAIDs) unless directed by a healthcare provider.
• Maintain a balanced diet low in sodium and protein if advised.
• Stay hydrated and monitor urine output for changes.
• Regular exercise and blood pressure control may support overall kidney health.

When to Seek Professional Help

Seek immediate medical attention if you experience:

• Sudden onset of blood in urine.
• Significant swelling (edema) in the legs, ankles, or face.
• Rapid weight gain or reduced urine output.
• Severe fatigue, nausea, or confusion (signs of kidney failure).
• Persistent high blood pressure despite treatment.

Tips for Medical Coders

Document the presence of diffuse endocapillary proliferative glomerulonephritis confirmed by biopsy to support the N01.4 code. Include details on the underlying cause (e.g., autoimmune, infectious) if known, as this may impact coding for associated conditions. Ensure laboratory results (e.g., hematuria, proteinuria) and clinical manifestations are clearly recorded to justify the diagnosis. Avoid coding for unspecified nephritic syndromes when the specific glomerulonephritis pattern is documented.